Home › Trial NCT07505069
Exploring the Clinical Value of RT01-89Zr PET Imaging in Solid Tumors
- Trial IDNCT07505069
- StatusRecruiting
- PhaseEarly Phase 1
- Study typeInterventional
- SponsorNanolattix Biotechnology Co., Ltd.
- Enrollment10
- Start date2026-01-29
- ConditionsSolid Tumors
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Human verification coming soon — the enriched analysis will be viewable here.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.